COMBINATION OF CD37 ANTIBODIES WITH ICE (IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE)

• 1. 一种用于制备聚乙交酯的催化剂组合物及聚乙交酯的制备方法 [P] . 中国专利： CN113773480A . 2021-12-10
• 2. 聚乙交酯共聚物组合物及其制备方法 [P] . 中国专利： CN112469782A . 2021-03-09
• 3. CD37 antibody and ICE (ifosfamide, carboplatin, etoposide) combination of [P] . 日本专利： JP2015517511A . 2015-06-22

  机译： CD37抗体与ICE（异环磷酰胺，卡铂，依托泊苷）的组合

• 4. COMBINATION OF CD37 ANTIBODIES WITH ICE (IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE) [P] . 世界知识产权组织专利： WO2013171287A1 . 2013-11-21

  机译： CD37抗体与冰的组合（异环磷酰胺，卡铂，乙交酯）

• 5. LENVATINIB IN COMBINATION WITH ETOPOSIDE AND IFOSFAMIDE FOR USE IN TREATING A TUMOR [P] . EP3338779B1 . 2021-06-30

  机译： Lenvatinib与Etoposide和Ifosfamide联合使用，用于治疗肿瘤

• 1. Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide- carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer： a retrospective analysis of 62 cases [J] . Yue-Ya Li, Chan Zhou, Deng-Xia Yang, 癌症生物学与医学：英文版 . 2015,第002期
• 2. Analysis of Efficacy of DICE (Dexamethasone, Ifosfamide,Cisplatin and Etoposide) Regimen on Recurrent and Refractory Intermediate and High Grade Non-Hodgkin's Lymphoma [J] . Lei Yang, Zhucheng Song, Xiaohong Xu, 癌症生物学与医学（英文版 ） . 2009,第001期
• 3. EFFICACY OF IFOSFAMIDE AND VP-16 (ETOPOSIDE) IN PATIENTS WITH SMALL CELL LUNG CANCER AND THE CORRELATION BETWEEN MICROVESSEL COUNT ON CHEMOSENSITIVITY [J] . WANG Si-wen, LIU Hong-xu, LI Yu 中国癌症研究（英文版） . 2006,第002期
• 4. Ifosfamide, Carboplatin, and Etoposide (ICE) in Combination with Regional Hyperthermia as Salvage Therapy in Patients with Locally Advanced Nonmetastatic and Metastatic Soft-Tissue Sarcoma [J] . Veit Bücklein, Christina Limmroth, Eric Kampmann, Sarcoma . 2020,第1期
• 5. Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma [J] . Hu Bei, Younes Anas, Westin Jason R., Leukemia and lymphoma . 2018,第3a4期
• 6. The NK-1 receptor-antagonist aprepitant in high-dose chemotherapy (high-dose melphalan and high-dose T-ICE: paclitaxel, ifosfamide, carboplatin, etoposide): efficacy and safety of a triple antiemetic combination. [J] . Jordan K, Jahn F, Jahn P, Bone marrow transplantation . 2011,第6期
• 7. Development and validation of a LC-MS/MS method for the simultaneous quantitation of carboplatin and etoposide in human plasma and ultrafiltrate [C] . Jessica Sima, Ganesh Moorthy, Athena Zuppa, ASMS Conference on Mass Spectrometry and Allied Topics . 2016
• 8. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018
• 9. Ifosfamide Carboplatin and Etoposide (ICE) in Combination with Regional Hyperthermia as Salvage Therapy in Patients with Locally Advanced Nonmetastatic and Metastatic Soft-Tissue Sarcoma [O] . Veit Bücklein, Christina Limmroth, Eric Kampmann, 2020
• 10. Comparison of Nutrition-Related Adverse Events and Clinical Outcomes Between ICE (Ifosfamide, Carboplatin, and Etoposide) and MCEC (Ranimustine, Carboplatin, Etoposide, and Cyclophosphamide) Therapies as Pretreatment for Autologous Peripheral Blood Stem Cell Transplantation in Patients with Malignant Lymphoma [O] . Takashi Aoyama, Osamu Imataki, Hidekazu Arai, 2018

• 1. Successful Treatment of Elderly Diffuse Large B-Cell Lymphoma with Central Nervous System Recurrence by Rituximab, Ranimusutine, Ifosfamide, Procarbazine, Dexamethasone, and Etoposide Therapy [J] . Junya Miyahara ,Naoki Takezako ,Miyuki Wagatsuma . 癌症治疗（英文） . 2013,第3期
• 2. Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide,carboplatin,epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil:A pilo [J] . Toru Ishikawa ,Michitaka Imai ,Hiroteru Kamimura . 世界胃肠病学杂志：英文版 . 2007,第41期
• 3. 紫杉醇、卡铂与异环磷酰胺、鬼臼乙叉甙、卡铂方案治疗晚期非小细胞肺癌的疗效比较 [C] . 李德宪 ,陈小冰 ,吕江清 . 中国抗癌协会临床肿瘤学协作中心第五届学术年会 . 2001
• 4. 开环聚合制备聚乙交酯和聚乙丙交酯及其性能表征 [A] . 熊俊瑶 . 2019